Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial : The Lancet
Links shared publicly online about this topic.
- 1,907total visits
Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial : The Lancet
Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial. By - Dr Ali S Taha MD,...
View full resource at thelancet.com
Tags: Gastroenterology, Peptic Ulcer, Gaster, Aspirin
Most Recently Shared on July 10, 2009 at 9:35 pm By:
Famotidine for GI prophylaxis in patient taking prolonged antiplatelet therapy - http://bit.ly/35z6t
Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial : The Lancet
thelancet.com — “Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial. By - Dr Ali S Taha MD,...” View full resource at thelancet.com
Most Recently Shared on July 10, 2009 at 12:43 pm By:
[The Lancet] [Articles] Famotidine for the prevention of peptic ulcers and oesophagitis in patients .. http://tinyurl.com/mlqxln
Advertisement
